Target intelligence / Profile preview

Extracellular matrix components including heparan sulfate proteoglycans (ECM/HSPGs)

Target
ECM/HSPGs
Molecular classification
Extracellular matrix protein, Proteoglycan, Glycoprotein
01

Overview

The extracellular matrix (ECM) is a complex non-cellular network of macromolecules, including proteins, glycosaminoglycans, and proteoglycans, that provides structural scaffolding and biochemical cues to tissues (Source: NIH National Cancer Institute). Heparan sulfate proteoglycans (HSPGs), such as syndecans and glypicans, are critical ECM components that regulate cell signaling by acting as co-receptors for growth factors like VEGF and FGF (Source: Bishop et al., 2007, Nature). These molecules are essential for maintaining tissue homeostasis, cell adhesion, and migration (Source: Sarrazin et al., 2011, Cold Spring Harb Perspect Biol). In diseases like cancer, the ECM is often remodeled and HSPGs are degraded by enzymes like heparanase, facilitating tumor invasion, angiogenesis, and metastasis (Source: Vlodavsky et al., 2012, Matrix Biology). Therapeutic interventions targeting the ECM/HSPG axis include HSPG mimetics like muparfostat, which sequester growth factors to inhibit tumor growth (Source: Zhou et al., 2011, Journal of Medicinal Chemistry). Furthermore, HSPGs serve as primary attachment sites for various pathogens, including SARS-CoV-2 and herpes simplex virus, making them targets for antiviral strategies (Source: Clausen et al., 2020, Cell).

Other names
Extracellular matrixHSPGsCell surface proteoglycansBasement membrane componentsGlycosaminoglycans
02

Mechanism of action

Competitive inhibition of growth factor binding to heparan sulfate chains; Inhibition of heparanase-mediated matrix degradation; Blocking of viral and bacterial attachment to cell surface proteoglycans

03

Biological functions

Signal transductionCell adhesionGrowth factor sequestrationStructural supportCell migration
04

Disease associations

CancerInflammationInfectionFibrosisCardiovascular disease
05

Safety considerations

Hemorrhage risk due to anticoagulant properties of heparin-like mimeticsImpaired wound healingOff-target effects on systemic growth factor signalingThrombocytopenia
06

Interacting drugs

Heparin

6 more in the full profile.

07

Biomarkers

Syndecan-1 (SDC1) serum levelsHeparanase (HPSE) activityCirculating heparan sulfate levelsCollagen degradation products

Beyond the preview

Go deeper on Extracellular matrix components including heparan sulfate proteoglycans (ECM/HSPGs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular matrix components including heparan sulfate proteoglycans (ECM/HSPGs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call